| |
|
September 2, 2010 | honors and awards
Paul Greengard receives Karolinska Institutet’s Bicentennial Gold Medal

| The gold medal is the highest award conferred by the Karolinska Institutet, one of the world’s leading medical universities, during its 200th anniversary celebrations. The medal recognizes the work of an individual not permanently located at the Karolinska Institutet, who has contributed to and has achieved acknowledged eminence in the university’s activities. |
|






|
July 27, 2010 | science news
MicroRNAs play a role in cocaine addiction

| MicroRNAs, short stretches of RNA that silence genes, have already been linked to cancer, heart disease and mental disorders such as schizophrenia. New research by Rockefeller University scientists suggests microRNAs are also involved in regulating the motivation to consume cocaine, a finding that could ultimately lead to new ways of combating addictive diseases in humans. |
|

|
July 26, 2010 | science news
Muscle gene may provide new treatments for obesity and diabetes

| In muscle, a protein called MED1 normally suppresses a genetic program that holds in check certain energy expenditure pathways. But when Rockefeller University scientists removed this gene in mice, a number of genes that are usually suppressed were activated, suggesting that targeting the Med1 gene could provide new therapeutical approaches to treating such metabolic diseases as obesity and diabetes. |
|



|
July 2, 2010 | honors and awards
Rockefeller postdoc named finalist for Blavatnik Awards for Young Scientists

| Agnel Sfeir, a postdoctoral fellow in Titia de Lange's Laboratory of Cell Biology and Genetics, has been named a finalist in the fourth annual Blavatnik Awards for Young Scientists competition, which recognizes the contributions of young scientists and engineers in New York, New Jersey and Connecticut. |
|

|
July 2, 2010 | science news
New HIV vaccine trial first to target dendritic cells

HIV has been able to outmaneuver every vaccine that's been tried on the virus since it was first discovered in 1981. But no vaccine has yet to directly employ what is arguably the most powerful weapon the human immune system, the dendritic cells that orchestrate the body's response to infection. Now that's about to change. Researchers at Rockefeller University, where dendritic cells were discovered in 1973, are building on decades worth of research to launch a novel vaccine trial in hopes of mustering an immune response strong enough to defeat the deadly virus. It's the first clinical trial of a dendritic cell based vaccine against infection, and researchers hope it will mark a turning point in the battle against AIDS.  |
|

|
June 18, 2010 | science news
New research shows how experience shapes the brain’s circuitry

The adult brain, long considered to be fixed in its wiring, is remarkably dynamic, according to new research by Rockefeller University scientists. The finding explains how the circuitry of a region of the mouse brain called the somatosensory cortex, which processes input from the various systems in the body that respond to the sense of touch, is continually modified by experience. |
|

|
June 18, 2010 | honors and awards
Winrich Freiwald named Pew Scholar

| A cognitive neuroscientist, who uses imaging techniques to study the parts of the brain responsible for visual processing, is the recipient of a prestigious Pew Scholars award. |
|



|
June 10, 2010 | science news
Alzheimer’s brain protein may provide target for treating mental retardation

| Reducing the level of β-amyloid, a protein found in the brains of patients with Alzheimer’s disease and Down syndrome, may improve the cognitive abilities of children with Down syndrome. The new study by Rockefeller University scientists may provide a model for developing new anti-amyloid drugs. |
|

|
June 9, 2010 | campus news
37 students to receive Ph.D.s at Rockefeller’s 52nd Commencement

| In addition to graduate degrees, two honorary doctorates will be awarded, to Hanna Holborn Gray, historian, president emeritus of The University of Chicago and chairman of the Howard Hughes Medical Institute; and Harold E. Varmus, Nobel laureate and president and chief executive of Memorial Sloan-Kettering Cancer Center. |
|



|
 |
|  |